2024-515436-76-00已完成4 期
The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatment and prevention of Influenza.
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 54
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Pharmacokinetic Study Team
Scientific
Adamed Pharma S.A.
研究点 (1)
Loading locations...
相似试验
招募中
4 期
The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatment of schizophrenia in adults patients.2025-523325-18-00Adamed Pharma S.A.36
招募中
4 期
The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatment of type 2 diabetes mellitus in adults and children aged 10 years and above, and heart failure and chronic kidney disease in adults patiens.2025-522976-10-00Adamed Pharma S.A.44
招募中
4 期
The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatment of schizophrenia in adult patients.2025-521400-21-00Adamed Pharma S.A.54
招募中
4 期
The pivotal bioequivalence study comparing the test product to the reference product, which belong to the group of medicines used in the treatment of type 2 diabetes mellitus when the condition cannot be adequately controlled by diet and exercise alone.2025-522975-27-00Adamed Pharma S.A.44
已完成
4 期
The pivotal bioequivalence study comparing the test product to the reference product, which belong to the group of medicines used in treatment of uncomplicated lower urinary tract infections.2024-518988-35-00Sciencepharma Sp. z o.o.34